Dr. Bibee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-5115Fax+1 434-244-4504
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2013 - 2014- Washington University in St. Louis School of MedicineClass of 2013
Certifications & Licensure
VA State Medical License 2024 - 2026
MD State Medical License 2019 - 2024
NC State Medical License 2020 - 2022
PA State Medical License 2014 - 2021
MO State Medical License 2013 - 2014- American Board of Dermatology Dermatology
Clinical Trials
- Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2024 Feb 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 20 citationsCutaneous squamous cell carcinoma in the organ transplant recipient.Kristin Bibee, Andrew Swartz, Shaum Sridharan, Cornelius H.L. Kurten, Charles B. Wessel
Oral Oncology. 2020-02-14 - 48 citationsInitial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus GuidelinesLauren D. Crow, Anokhi Jambusaria-Pahlajani, Christina L. Chung, David A. Baran, Stefan E. Lowenstein
Transplant International. 2019-12-01 - 7 citationsNivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu
Journal of Clinical Oncology. 2024-03-20
Press Mentions
Study Finds Higher Risk of Skin Cancer After Childhood Organ TransplantJune 28th, 2022- Surveillance of Regional Nodal Basins and Gene Expression Profiling in Patients with Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and NeckJuly 22nd, 2023
- New Tools on the Horizon for Managing cSCC in Solid Organ Transplant RecipientsFebruary 9th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
